Appropriate selection of biochemical targets is one of the most important drivers of cost effectiveness in the discovery of new medicines. Despite the many advances in genetics, genomics and systems biology, validation of a target is not achieved until therapeutic efficacy is demonstrated by a drug candidate.Volume 46 of this series reviews the medicinal chemistry aimed at six diverse targets from which important new medicines are emerging: HIV integrase (discovery of the first-in-class inhibitor drug raltegravir), 11-beta-Hydroxysteroid dehydrogenase (new approach to glucocorticoid regulation), nicotinic a7 choline receptor (agonists and positive allosteric modulators), bradykinin receptor (new approach to pain therapy); histone deacetylase (new drugs for cancer), and 5-HT2c receptor modulators (various CNS indications). This book presents the latest research in the field of drug discovery. It publishes on an annual basis to bring you the most innovative updates in medicinal chemistry. It is available as an online resource via ScienceDirect.
具體描述
讀後感
評分
評分
評分
評分
用戶評價
相關圖書
本站所有內容均為互聯網搜索引擎提供的公開搜索信息，本站不存儲任何數據與內容，任何內容與數據均與本站無關，如有需要請聯繫相關搜索引擎包括但不限於百度，google,bing,sogou 等
© 2025 qciss.net All Rights Reserved. 小哈圖書下載中心 版权所有